7,277
Views
1
CrossRef citations to date
0
Altmetric
2021 Annual A&WMA Critical Review

Critical review on PFOA, kidney cancer, and testicular cancer

ORCID Icon &

References

  • 3M. 3M’s commitment to PFAS stewardship. Accessed March 1, 2021. https://www.3m.com/3M/en_US/pfas-stewardship-us/pfas-history/
  • Agency for Toxic Substances and Disease Registry (ATSDR). 2018. Toxicological profile for perfluoroalkyls. (Draft for public comment). Atlanta, GA, U.S.: Department of Health and Human Services, Public Health Service.
  • American Cancer Society. 2020b.Key statistics for testicular cancer. January 8. Accessed January 18, 2021. https://www.cancer.org/cancer/testicular-cancer/about/key-statistics.html
  • American Cancer Society (ACS). 2020a. Key statistics about kidney cancer. American Cancer Society, January 8. Accessed January 18, 2021. https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html
  • Andrews, D. 2018. Report: Up to 110 million Americans could have PFAS-contaminated drinking water. Environmental Working Group, May 22. Accessed March 1, 2021. https://www.ewg.org/research/report-110-million-americans-could-have-pfas-contaminated-drinking-water
  • Australia Expert Health Panel for PFAS. 2018. Australian government, department of health. Combined Report, May 7. https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-pfas-expert-panel.htm
  • Avanasi, R., H. M. Shin, V. M. Vieira, and S. M. Bartell. 2016. Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 health project population. Environ. Res. 146:299–307. doi:10.1016/j.envres.2016.01.011.
  • Barry, V., A. Winquist, and K. Steenland. 2013. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ. Health Perspect. 121:1313–18. doi:10.1289/ehp.1306615.
  • Bartell, S. M. 2017. Online serum PFOA calculator for adults. Environ. Health Perspect. 125:104502. doi:10.1289/EHP2820.
  • Bartell, S. M. 2019. Understanding and mitigating the replication crisis, for environmental epidemiologists. Curr. Environ. Health Rep. 6:8–15. doi:10.1007/s40572-019-0225-4.
  • Bartell, S. M., A. M. Calafat, C. Lyu, K. Kato, P. B. Ryan, and K. Steenland. 2010. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ. Health Perspect. 118 (2):222–28. doi:10.1289/ehp.0901252.
  • C8 Science Panel. 2012. C8 science panel probable link reports [website]. updated October 29. Accessed January 18, 2021. http://www.c8sciencepanel.org/prob_link.html
  • Chandler, J., M. Cumpston, J. Thomas, J. P. T. Higgins, J. J. Deeks, M. J. Clarke, and I. Chapter. 2020. Introduction. In ed.. J. P. T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. J. Page, and V. A. Welch, Cochrane handbook for systematic reviews of interventions version 6.1. Cochrane. The Cochrane Collaboration. Accessed September 2020. www.training.cochrane.org/handbook
  • Chang, E. T., H. O. Adami, P. Boffetta, P. Cole, T. B. Starr, and J. S. Mandel. May 2014. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans. Crit. Rev. Toxicol. 44(Suppl 1):1–81. doi: 10.3109/10408444.2014.905767.
  • Consonni, D., K. Straif, J. M. Symons, J. A. Tomenson, L. G. P. M. van Amelsvoort, A. Sleeuwenhoek, J. W. Cherrie, P. Bonetti, I. Colombo, D. G. Farrar, et al. 2013. Cancer risk among Tetrafluoroethylene synthesis and polymerization workers. Am. J. Epidemiol. 178(3):350–58. doi:10.1093/aje/kws588.
  • de Silva, A. O., J. M. Armitage, T. A. Bruton, C. Dassuncao, W. Heiger–Bernays, X. C. Hu, A. Kärrman, B. Kelly, C. Ng, A. Robuck, et al. 2021. PFAS exposure pathways for humans and wildlife: A synthesis of current knowledge and key gaps in understanding. Environ. Toxicol. Chem. 40:631–57. doi:10.1002/etc.4935.
  • European Food Safety Authority (EFSA), Panel on Contaminants in the Food Chain. 2018. Scientific opinion on the risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. Efsa J. 16(12):5194.
  • Frisbee, S. J., A. P. Brooks Jr, A. Maher, P. Flensborg, S. Arnold, T. Fletcher, K. Steenland, A. Shankar, S. S. Knox, C. Pollard, et al. 2009. The C8 health project: Design, methods, and participants. Environ. Health Perspect. December 117(12):1873–82. doi: 10.1289/ehp.0800379.
  • Gilliland, F. D., and J. S. Mandel. September 1993. Mortality among employees of a perfluorooctanoic acid production plant. J. Occup. Environ. Med. 35(9):950–54. doi: 10.1097/00043764-199309000-00020.
  • Gomis, M. I., R. Vestergren, H. Nilsson, and I. Cousins. 2016. Contribution of direct and indirect exposure to human serum concentrations of perfluorooctanoic acid in an occupationally exposed group of ski waxers. Environ. Sci. Technol. 50:7037–46. doi:10.1021/acs.est.6b01477.
  • Haug, L. S., S. Huber, G. Becher, and C. Thomsen. 2011. Characterisation of human exposure pathways to perfluorinated compounds — Comparing exposure estimates with biomarkers of exposure. Environ. Int. 37:687–93. doi:10.1016/j.envint.2011.01.011.
  • Hernán, M. A., S. Hernández-Díaz, M. M. Werler, and A. A. Mitchell. 2002. Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am. J. Epidemiol. 155:176–84. doi:10.1093/aje/155.2.176.
  • Hertz-Picciotto, I. 1995. Epidemiology and quantitative risk assessment: A bridge from science to policy. Am. J. Public Health 85 (4):484–91. doi:10.2105/ajph.85.4.484.
  • Higgins, J. P. T., and S. G. Thompson. 2002. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21 (11):1539–58. doi:10.1002/sim.1186.
  • Hill, A. B. 1965. The environment and disease: Association or causation? Proc. R. Soc. Med. 58:295–300.
  • Hu, X. C., D. Q. Andrews, A. B. Lindstrom, T. A. Bruton, L. A. Schaider, P. Grandjean, R. Lohmann, C. C. Carignan, A. Blum, S. A. Balan, et al. 2016. Detection of poly- and perfluoroalkyl substances (PFASs) in U.S. Drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants. Environ. Sci. Technol. Lett. 3:344–50. doi:10.1021/acs.estlett.6b00260.
  • International Agency for Research on Cancer (IARC) Working Group. 2016. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 110. Lyon, France: IARC. Some Chemicals Used as Solvents and in Polymer Manufacture.
  • Interstate Technology and Regulatory Council (ITRC). PFAS technical and regulatory guidance document and fact sheets PFAS-1. Washington, DC: ITRC PFAS Team. Accessed March 1, 2021. https://pfas-1.itrcweb.org
  • Kim, S. B., S. M. Bartell, and D. L. Gillen. 2015. Estimation of a benchmark dose in the presence or absence of hormesis using posterior averaging. Risk Anal. 35 (3):396–408. doi:10.1111/risa.12294.
  • Kotlarz, N., J. McCord, D. Collier, C. S. Lea, M. Strynar, A. B. Lindstrom, A. A. Wilkie, J. Y. Islam, K. Matney, P. Tarte, et al. 2020. Measurement of novel, drinking water-associated PFAS in blood from adults and children in Wilmington, North Carolina. Environ. Health Perspect. July 128(7):77005. doi: 10.1289/EHP6837.
  • Leonard, R. C., K. H. Kreckmann, C. J. Sakr, and J. M. Symons. 2008. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann. Epidemiol. 18 (1):15–22. doi:10.1016/j.annepidem.2007.06.011.
  • Li, Y., Y. Xu, K. Scott, C. Lindh, K. Jakobsson, and T. Fletcher. 2019. Half-lives of PFOA, PFPeS, PFHxS, PFHpS and PFOS after end of exposure to contaminated drinking water. Environ. Epidemiol. 3:237. doi:10.1097/01.EE9.0000608476.06577.16.
  • Lorber, M., and P. P. Egeghy. 2011. Simple intake and pharmacokinetic modeling to characterize exposure of Americans to perfluoroctanoic acid, PFOA. Environ. Sci. Technol. October 1. 4519: 8006–14.doi: 10.1021/es103718h
  • Lu, S., and S. M. Bartell 2019. Serum PFAS calculator for adults, version 1.1. Accessed May 25, 2020. www.ics.uci.edu/~sbartell/pfascalc.html
  • Mastrantonio, M., E. Bai, R. Uccelli, V. Cordiano, A. Screpanti, and P. Crosignani. 2018. Drinking water contamination from perfluoroalkyl substances (PFAS): An ecological mortality study in the Veneto region, Italy. Eur. J. Public Health 28 (1):180–85. doi:10.1093/eurpub/ckx066.
  • Michigan PFAS Action Response Team. 2021. PFAS response/investigations: Rockford Tannery, Rockford, Kent County. Michigan Department of Environment, Great Lakes, and Energy. February 22. Lansing, Michigan. Accessed March 1, 2021. https://www.michigan.gov/pfasresponse/0,9038,7-65-86511_82704-488796–,00.html.
  • Munafò, M. R., and G. Davey Smith. 2018. Robust research needs many lines of evidence. Nature January 25. 5537689: 399–401.doi: 10.1038/d41586-018-01023-3
  • National Toxicology Program (NTP). Technical report on the toxicology and carcinogenesis studies of perfluorooctanoic acid (CASRN 335-67-1) administered in feed to Sprague Dawley Rats. Technical Report 598, North Carolina, USA: National Toxicology Program, Public Health Service, U.S. Department of Health and Human Services, Research Triangle Park. May 2020.
  • New Hampshire Department of Health and Human Services. 2018. Cancer Incidence Report: Merrimack, NH. Division of Public Health Services, January. Accessed April 21, 2021. https://www.dhhs.nh.gov/dphs/pfcs/documents/merrimack-cancer-012018.pdf.
  • Norman, J. 1992. One-compartment kinetics. Br. J. Anaesth. 69:387–96. doi:10.1093/bja/69.4.387.
  • Olsen, G. W., J. M. Burris, D. J. Ehresman, J. W. Froehlich, A. M. Seacat, J. L. Butenhoff, L. R. Zobel. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115(9):1298–305. doi:10.1289/ehp.10009.
  • Post, G. B., J. A. Gleason, K. R. Cooper, and L. S. Birnbaum. 2017. Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: Contaminants of emerging concern. PLoS Biol. December 20. 1512: e2002855. doi: 10.1371/journal.pbio.2002855
  • Raleigh, K. K., B. H. Alexander, G. W. Olsen, G. Ramachandran, S. Z. Morey, T. R. Church, P. W. Logan, L. L. F. Scott, E. M. Allen. 2014. Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occup. Environ. Med. 71:500–06. doi:10.1136/oemed-2014-102109.
  • Rothman, K. J., and S. Greenland. 2005. July 1. Causation and causal inference in epidemiology. Am. J. Public Health 95S1: S144–S150. doi: 10.2105/AJPH.2004.059204
  • Russell, M. H., R. L. Waterland, and F. Wong. 2015. Calculation of chemical elimination half-life from blood with an ongoing exposure source: The example of perfluorooctanoic acid (PFOA). Chemosphere 129:210–16. doi:10.1016/j.chemosphere.2014.07.061.
  • Samet, J. M., S. Bartell, L. Bero, A. Bostrom, K. Dickersin, D. C. Dorman, D. L. Eaton. 2014. Review of EPA’s integrated risk information system (IRIS) process. Washington, D.C.: National Academies Press.
  • Shearer, J. J., C. L. Callahan, A. M. Calafat, W. Y. Huang, R. R. Jones, V. S. Sabbisetti, N. D. Freedman, J. N. Sampson, D. T. Silverman, M. P. Purdue. et al. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma. JNCI 2020. djaa143, doi:10.1093/jnci/djaa143. corrected proof.
  • Shin, H. M., V. M. Vieira, P. B. Ryan, K. Steenland, and S. M. Bartell. 2011b. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 health project. Environ. Health Perspect. 119 (12):1760–65. doi:10.1289/ehp.1103729.
  • Shin, H. M., V. M. Vieira, P. B. Ryan, R. Detwiler, B. Sanders, K. Steenland, and S. M. Bartell. 2011a. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington works facility in West Virginia. Environ. Sci. Technol. 45 (4):1435–42. doi:10.1021/es102769t.
  • Steenland, K., and A. Winquist. 2021. PFAS and cancer, a scoping review of the epidemiologic evidence. Environ. Res. 194:110690. doi:10.1016/j.envres.2020.110690.
  • Steenland, K., and S. Woskie. 2012. Cohort mortality study of workers exposed to perfluorooctanoic acid. Am. J. Epidemiol. November 15. 17610: 909–17.doi: 10.1093/aje/kws171
  • Steenland, K., T. Fletcher, C. R. Stein, S. M. Bartell, L. Darrow, M. J. Lopez-Espinosa, P. B. Ryan, and D. A. Savitz. 2020. Commentary: Evolution of evidence on PFOA and health following the assessments of the C8 science panel. Environ. Int. 145:106125. doi:10.1016/j.envint.2020.106125.
  • Sterne, J. A. C., M. A. Hernán, A. McAleenan, B. C. Reeves, and J. P. T. Higgins. 2020. Chapter 25: Assessing risk of bias in a non-randomized study. ed.. J. P. T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. J. Page, and V. A. Welch, Cochrane handbook for systematic reviews of interventions version 6.1. Cochrane. The Cochrane Collaboration. Accessed September 2020. www.training.cochrane.org/handbook
  • Strynar, M., S. Dagnino, R. McMahen, S. Liang, A. Lindstrom, E. Andersen, L. McMillan, M. Thurman, I. Ferrer, and C. Ball. 2015. Identification of novel perfluoroalkyl ether carboxylic acids (PFECAs) and sulfonic acids (PFESAs) in natural waters using accurate mass time-of-flight mass spectrometry (TOFMS). Environ. Sci. Technol. 49:11622–30. doi:10.1021/acs.est.5b01215.
  • Sun, Q., G. Zong, D. Valvi, F. Nielsen, B. Coull, and P. Grandjean. 2018. Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: A prospective investigation among U.S. women. Environ. Health Perspect. 126 (3):037001. doi:10.1289/EHP2619.
  • Sunderland, E. M., X. C. Hu, C. Dassuncao, A. K. Tokranov, C. C. Wagner, and J. G. Allen. 2019. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J. Expo. Sci. Environ. Epidemiol. March 29(2):131–47. doi: 10.1038/s41370-018-0094-1.
  • Szklo, M., and F. J. Nieto. 2019. Epidemiology: Beyond the basics. 4th ed. Boston, MA: Jones & Bartlett Learning.
  • Temkin, A. M., B. A. Hocevar, D. Q. Andrews, O. V. Naidenko, and L. M. Kamendulis. 2020. Application of the key characteristics of carcinogens to per and polyfluoroalkyl substances. Int. J. Environ. Res. Public Health March 4. 175: 1668.doi: 10.3390/ijerph17051668
  • U.S. Environmental Protection Agency. 30 May 2006. Report of the perfluorooctanoic acid review panel. Washington, DC: Science Advisory Board.
  • US Environmental Protection Agency. 2016. Health effects support document for perfluorooctanoic acid (PFOA). Office of Water, May. EPA 822-R-16-003.
  • van Reekum, R., D. L. Streiner, and D. K. Conn. 2001. Applying Bradford Hill’s criteria for causation to neuropsychiatry. J. Neuropsychiatry Clin. Neurosci. 13 (3):318–25. doi:10.1176/jnp.13.3.318.
  • van Wijngaarden, E., and I. Hertz-Picciotto. 2004. A simple approach to performing quantitative cancer risk assessment using published results from occupational epidemiology studies. Sci. Total Environ. 332:81–87. doi:10.1016/j.scitotenv.2004.04.005.
  • Vieira, V. M., K. Hoffman, H. M. Shin, J. M. Weinberg, T. F. Webster, and T. Fletcher. 2013. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: A geographic analysis. Environ. Health Perspect. 121:318–23. doi:10.1289/ehp.1205829.
  • Weisskopf, M. G., and T. F. Webster. 2017. Trade-offs of personal versus more proxy exposure measures in environmental epidemiology. Epidemiology (Cambridge, Mass.) 28 (5):635–43. doi:10.1097/EDE.0000000000000686.
  • Zhang, Y., S. Beesoon, L. Zhu, and J. W. Martin. 2013. Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ. Sci. Technol. 47 (18):10619–27. doi:10.1021/es401905e.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.